Serum Chairman Says Company Held Early Merger Talks With Cipla

Serum Institute of India Ltd., Asia’s largest vaccine maker, held preliminary discussions with generic drugmaker Cipla Ltd. on a merger, Chairman Cyrus Poonawalla said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.